On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

Has a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

Alkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...

Quadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...

Heart medicines led sales in 2025, a trend set to continue. Respiratory and anti-diabetes drugs followed. Cardiac drug sales grew 13%, with...

The revival was on the back of therapies, including cardiac and anti-diabetic, which grew by 19.5% and 9.7% respectively in October (over S...

Indians spent over Rs 1,36,000 cr on medicines in last one year ending September 2019. People spent over Rs 17,000 cr on cardiac drugs, aro...

The product will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said in a statement.

BVS used as an implant during an angioplasty procedure is a tube device that clears blockages in arteries that carry blood to the heart whi...

The overall coverage of new medicines being added to the NLEM will be nearly Rs 8,000 crore in the organized pharma retail market.

One of the products recall in the world’s largest drug market by the US arm of Sun Pharma, India’s largest drugmaker by market capitalisati...

India’s largest drugmaker by market capitalisation Sun Pharma whose US arm recalled one of the products sold in the world’s largest drug ma...